Physician

Aarti Campo, M.D.

According to 2025 Medicare claims, Aarti Campo, M.D. (NPI: 1710189949) practices cardiology in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Dutchess, NY. This provider's primary affiliated billing organization is HUDSON VALLEY CARDIOVASCULAR PRACTICE, PC (NPI: 1922435882; TIN: 463756713) and primary practice location at 12524-2990. Campo is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Campo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,704 traditional Medicare patients, billed 6,518 HCPCS/CPT codes, and received $256,056 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,844 prescription claims across 704 beneficiaries totaling $1,203,928 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 2 records totaling $42. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $95,326 to $256,056. Similarly, Part D prescription costs have risen steadily, from $75,752 to $1,203,928. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	914	1,805	$95,326
2016	1,094	1,944	$91,507
2017	1,655	3,084	$130,820
2018	1,782	3,792	$196,417
2019	1,818	4,336	$216,013
2020	1,406	3,739	$170,320
2021	1,704	4,515	$232,547
2022	1,741	4,512	$237,398
2023	1,618	4,025	$204,881
2024	1,704	6,518	$256,056

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	221	1,448	$75,752
2016	286	2,171	$130,099
2017	297	1,717	$109,285
2018	195	1,129	$72,888
2019	253	1,569	$143,891
2020	297	2,182	$265,448
2021	371	2,537	$409,580
2022	468	3,221	$678,219
2023	585	4,089	$941,802
2024	704	4,844	$1,203,928

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	546	1,097	$100
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	489	494	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	428	779	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	504	773	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	446	547	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	368	25,006	$474,118
Entresto	Sacubitril/Valsartan	141	9,768	$209,515
Xarelto	Rivaroxaban	50	3,210	$59,238
Farxiga	Dapagliflozin Propanediol	49	2,610	$45,791
Repatha Syringe	Evolocumab	11	532	$10,772

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$42	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aarti Campo, M.D.?

Tedicare shows public-source Medicare data for Aarti Campo, M.D. (NPI 1710189949), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aarti Campo, M.D. have ACO affiliation data?

Aarti Campo, M.D. is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Aarti Campo, M.D.?

Aarti Campo, M.D. is linked to HUDSON VALLEY CARDIOVASCULAR PRACTICE, PC (billing NPI 1922435882) in the available physician profile data.

Does Aarti Campo, M.D. have Open Payments data?

Aarti Campo, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.